甲状腺毒素诱导的带断裂导致严重的 mitra 反:手术管理和门诊恢复
Rohit Pandit1, Ahmed Abu-Haniyeh1, Aws Polina1
1TidalHealth Hospital, Salisbury, Maryland, USA.
JACC. Case reports
|December 12, 2025
概括
甲状腺毒性病可以导致严重的心脏膜损伤,包括心肌吐和带破裂. 及时的内分泌和心脏管理对于受影响患者的最佳结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 心脏外科手术 心脏外科手术
背景情况:
- 甲状腺毒性病通常伴有心电节律失常和高输出心脏状态.
- 结构性膜衰竭是甲状腺毒性病的罕见但严重的并发症.
研究的目的:
- 报告一种罕见的甲状腺毒素症引起的中枢结构性衰竭病例.
- 强调内分泌和心脏管理协调的重要性.
主要方法:
- 一例病例介绍,一名57岁的男子患有新发的甲状腺毒性病,心房动,以及由于带状脉断裂而引起的严重腹.
- 用甲基马和β阻塞进行医疗稳定,随后进行中枢置换.
- 术后管理包括治疗左心室功能障碍,治疗心房动的阿米奥达龙和治疗抗凝血的阿皮克萨班.
主要成果:
- 患者呈现出从弦突破导致的前侧叶片的次要流性 mitrale 吐.
- 由于严重的损伤阻止了修复,因此进行了用生物假体替换中枢门.
- 手术后的康复包括左心室功能改善和维持鼻节律.
结论:
- 甲状腺毒性病可以通过高动力压力和矩阵重塑诱导心脏门的显著结构损伤.
- 术前内分泌优化和术后管理对于预防并发症至关重要.
- 虽然中枢门修复是首选的,但当修复不可行时,则需要更换;协调的内分泌心脏护理和个性化抗凝治疗是必不可少的.
相关概念视频
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Mitral Regurgitation IV: Nursing Management
286
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
286
Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Mitral Valve Prolapse III: Nursing Management
262
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
262


